Sfoglia per AUTORE
FASSNACHT M
Collezione AOU San Luigi di Orbassano

  

Items : 20

International consensus on mitotane treatment in pediatric patients with adrenal cortical tumors: indications, therapy, and management of adverse effects. in European journal of endocrinology / Eur J Endocrinol. 2024 Mar 30;190(4):G15-G24. doi: 10.1093/ejendo/lvae038.

2024
AOU San Luigi di Orbassano

Riedmeier M; Antonini SRR; Brandalise S; Costa TEJB; Daiggi CM; de Figueiredo BC; de Krijger RR; De Sá Rodrigues KE; Deal C; Del Rivero J; Engstler G; Fassnacht M; Fernandes Luiz Canali GC; Molina CAF; Gonc EN; Gültekin M; Haak HR; Guran T; Hendriks Allaird EJ; Idkowiak J; Kuhlen M; Malkin D; Meena JP; Pamporaki C; Pinto E; Puglisi S; Ribeiro RC; Thompson LDR; Yalcin B; et alii...

The Value of Local Therapies in Advanced Adrenocortical Carcinoma. in Cancers / Cancers (Basel). 2024 Feb 7;16(4):706. doi: 10.3390/cancers16040706.

2024
AOU San Luigi di Orbassano

Altieri B; Kimpel O; Laganà M; Vogl TJ; Adwan H; Dusek T; Basile V; Pittaway J; Dischinger U; Quinkler M; Kroiss M; Puglisi S; Cosentini D; Kickuth R; Kastelan D; Fassnacht M;

Comorbidities in mild autonomous cortisol secretion and the effect of treatment: systematic review and meta-analysis. in European journal of endocrinology / Eur J Endocrinol. 2023 Oct 17;189(4):S88-S101. doi: 10.1093/ejendo/lvad134.

2023
AOU San Luigi di Orbassano

Pelsma ICM; Fassnacht M; Tsagarakis S; Terzolo M; Tabarin A; Sahdev A; Newell-Price J; Marina L; Lorenz K; Bancos I; Arlt W; Dekkers OM;

Corrigendum to "Adrenocortical carcinomas and malignant phaeochromocytomas: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up": [Annals of Oncology volume 31 (2020) 1476-1490]. in Annals of oncology : official journal of the European Society for Medical Oncology / Ann Oncol. 2023 Jul;34(7):631. doi: 10.1016/j.annonc.2022.12.006. Epub 2022 Dec 21.

2023
AOU San Luigi di Orbassano

Berruti A; Terzolo M; de Krijger R; Porpiglia F; Haak HR; Fouchardiere C; Baudin E; Eisenhofer G; Assie G; Fassnacht M;

ENDOCRINE TUMOURS: Our experience with the management of patients with non-metastatic adrenocortical carcinoma. in European journal of endocrinology / Eur J Endocrinol. 2022 Jul 19;187(3):R27-R40. doi: 10.1530/EJE-22-0260. Print 2022 Sep 1.

2022
ASL Torino 4
AOU San Luigi di Orbassano

Fassnacht M; Terzolo M;

Adjuvant platinum-based chemotherapy in radically resected adrenocortical carcinoma: a cohort study. in British journal of cancer / Br J Cancer. 2021 Oct;125(9):1233-1238. doi: 10.1038/s41416-021-01513-8. Epub 2021 Aug 16.

2021
AOU San Luigi di Orbassano

Kimpel O; Bedrose S; Megerle F; Berruti A; Terzolo M; Kroiss M; Mai K; Dekkers OM; Habra MA; Fassnacht M;

S-GRAS score for prognostic classification of adrenocortical carcinoma: an international, multicenter ENSAT study. in European journal of endocrinology / Eur J Endocrinol. 2021 Nov 30;186(1):25-36. doi: 10.1530/EJE-21-0510.

2021
ASL Torino 4
AOU San Luigi di Orbassano

Cosentini D; Berhane S; Altieri B; Elhassan YS; Calabrese A; Haissaguerre M; Kastelan D; Fragoso MCBV; Bertherat J; Al Ghuzlan A; Haak H; Boudina M; Canu L; Loli P; Sherlock M; Kimpel O; Laganà M; Sitch AJ; Kroiss M; Arlt W; Terzolo M; Berruti A; Deeks JJ; Libé R; Fassnacht M; Ronchi CL;

ENSAT registry-based randomized clinical trials for adrenocortical carcinoma. in European journal of endocrinology / Eur J Endocrinol. 2021 Feb;184(2):R51-R59. doi: 10.1530/EJE-20-0800.

2021
AOU San Luigi di Orbassano

Quinkler M; Trofimiuk-Müldner M; Bancos I; Shafigullina Z; Vroonen L; Morelli V; Aylwin S; Van Slycke S; de Krijger R; Feelders R; Rodien P; Loli P; Dennedy MC; Vantyghem MC; Sherlock M; De Martino MC; Bugalho MJ; Romero MT; Nowak KM; Newell-Price J; Paiva I; Bourdeau I; Assié G; Arnaldi G; Yiannakopoulou E; Osher E; Kastelan D; Canu L; Kiriakopoulos A; et alii...

Data set for reporting of carcinoma of the adrenal cortex: explanations and recommendations of the guidelines from the International Collaboration on Cancer Reporting. in Human pathology / Hum Pathol. 2021 Apr;110:50-61. doi: 10.1016/j.humpath.2020.10.001. Epub 2020 Oct 12.

2021
AOU San Luigi di Orbassano
AOU Città della Salute di Torino

Gill AJ; Volante M; Thompson LDR; Papotti M; Sasano H; Mete O; Papathomas T; Fassnacht M; de Krijger RR; Erickson L; Berney D; Giordano TJ;

Adrenocortical carcinomas and malignant phaeochromocytomas: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up. in Annals of oncology : official journal of the European Society for Medical Oncology / Ann Oncol. 2020 Nov;31(11):1476-1490. doi: 10.1016/j.annonc.2020.08.2099. Epub 2020 Aug 27.

2020
AOU San Luigi di Orbassano

Terzolo M; de Krijger R; Porpiglia F; Haak HR; de la Fouchardiere C; Baudin E; Eisenhofer G; Assie G; Fassnacht M; Berruti A;

Effects of Germline CYP2W1*6 and CYP2B6*6 Single Nucleotide Polymorphisms on Mitotane Treatment in Adrenocortical Carcinoma: A Multicenter ENSAT Study. in Cancers / Cancers (Basel). 2020 Feb 4;12(2):359. doi: 10.3390/cancers12020359.

2020
AOU San Luigi di Orbassano

Terzolo M; Kroiss M; Chortis V; Angelousi A; Canu L; Kienitz T; Mannelli M; Quinkler M; Pontecorvi A; Calabrese A; Della Casa S; De Francia S; Herterich S; Sbiera S; Altieri B; Fassnacht M; Ronchi CL;

Expression of SOAT1 in Adrenocortical Carcinoma and Response to Mitotane Monotherapy: An ENSAT Multicenter Study. in The Journal of clinical endocrinology and metabolism / J Clin Endocrinol Metab. 2020 Aug 1;105(8):dgaa293. doi: 10.1210/clinem/dgaa293.

2020
AOU San Luigi di Orbassano

Fassnacht M; Sbiera S; Paiva I; Della Casa S; Volante M; Canu L; Berruti A; Ronchi CL; Megerle F; Zerbini MCN; Schreiner J; Kircher S; Landwehr LS; Basile V; Lacombe AMF; Altieri B; Weigand I; Fragoso MCBV; Terzolo M; Kroiss M;

European Society of Endocrinology Clinical Practice Guidelines on the management of adrenocortical carcinoma in adults, in collaboration with the European Network for the Study of Adrenal Tumors. in European journal of endocrinology / Eur J Endocrinol. 2018 Oct 1;179(4):G1-G46. doi: 10.1530/EJE-18-0608.

2018
AOU San Luigi di Orbassano

Fassnacht M; Dekkers OM; Else T; Baudin E; Berruti A; de Krijger R; Haak HR; Mihai R; Assie G; Terzolo M;

Assessment of VAV2 Expression Refines Prognostic Prediction in Adrenocortical Carcinoma. in The Journal of clinical endocrinology and metabolism / J Clin Endocrinol Metab. 2017 Sep 1;102(9):3491-3498. doi: 10.1210/jc.2017-00984.

2017
AOU San Luigi di Orbassano

Sbiera S; Sbiera I; Ruggiero C; Doghman-Bouguerra M; Korpershoek E; de Krijger RR; Ettaieb H; Haak H; Volante M; Papotti M; Reimondo G; Terzolo M; Luconi M; Nesi G; Mannelli M; Libé R; Ragazzon B; Assié G; Bertherat J; Altieri B; Fadda G; Rogowski-Lehmann N; Reincke M; Beuschlein F; Fassnacht M; Lalli E;

Topoisomerase 2? and thymidylate synthase expression in adrenocortical cancer. in Endocrine-related cancer / Endocr Relat Cancer. 2017 Jul;24(7):319-327. doi: 10.1530/ERC-17-0095. Epub 2017 Apr 21.

2017
AOU San Luigi di Orbassano

Roca E; Berruti A; Sbiera S; Rapa I; Oneda E; Sperone P; Ronchi CL; Ferrari L; Grisanti S; Germano A; Zaggia B; Scagliotti GV; Fassnacht M; Volante M; Terzolo M; Papotti M;

Prognostic role of overt hypercortisolism in completely operated patients with adrenocortical cancer. in European urology / Eur Urol. 2014 Apr;65(4):832-8. doi: 10.1016/j.eururo.2013.11.006. Epub 2013 Nov 14.

2014
AOU San Luigi di Orbassano

Berruti A; Fassnacht M; Haak H; Else T; Baudin E; Sperone P; Kroiss M; Kerkhofs T; Williams AR; Ardito A; Leboulleux S; Volante M; Deutschbein T; Feelders R; Ronchi C; Grisanti S; Gelderblom H; Porpiglia F; Papotti M; Hammer GD; Allolio B; Terzolo M;

Prognostic factors of overall survival of stage III or IV adrenocortical carcinomas (ACC): A multicenter ENS@T study in Journal of Clinical Oncology

2014
AOU San Luigi di Orbassano

Libe R; Borget I; Ronchi CL; Ardito A; Kroiss M; Bertherat J; Quinkler M; Bala M; Beuschlein F; Vezzosi D; Haak H; Leboulleux S; Zaggia B; Fassnacht M; Baudin E;

Mitotane levels predict the outcome of patients with adrenocortical carcinoma treated adjuvantly following radical resection. in European journal of endocrinology / Eur J Endocrinol. 2013 Jul 29;169(3):263-70. doi: 10.1530/EJE-13-0242. Print 2013 Sep.

2013
AOU San Luigi di Orbassano

Terzolo M; Baudin AE; Ardito A; Kroiss M; Leboulleux S; Daffara F; Perotti P; Feelders RA; deVries JH; Zaggia B; De Francia S; Volante M; Haak HR; Allolio B; Al Ghuzlan A; Fassnacht M; Berruti A;

Adrenal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. in Annals of oncology : official journal of the European Society for Medical Oncology / Ann Oncol. 2012 Oct;23 Suppl 7:vii131-8. doi: 10.1093/annonc/mds231.

2012
AOU San Luigi di Orbassano

Berruti A; Baudin E; Gelderblom H; Haak HR; Porpiglia F; Fassnacht M; Pentheroudakis G;

Ribonucleotide reductase large subunit (RRM1) gene expression may predict efficacy of adjuvant mitotane in adrenocortical cancer. in Clinical cancer research : an official journal of the American Association for Cancer Research / Clin Cancer Res. 2012 Jun 15;18(12):3452-61. doi: 10.1158/1078-0432.CCR-11-2692. Epub 2012 Apr 30.

2012
AOU San Luigi di Orbassano

Volante M; Terzolo M; Fassnacht M; Rapa I; Germano A; Sbiera S; Daffara F; Sperone P; Scagliotti G; Allolio B; Papotti M; Berruti A;